References
- Brown-Elliott BA, Griffith DE, Wallace RJ Jr. Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am 2002;16:187-220 https://doi.org/10.1016/S0891-5520(03)00052-7
- Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002;15:716-46 https://doi.org/10.1128/CMR.15.4.716-746.2002
- Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997;156:S1-25 https://doi.org/10.1164/ajrccm.156.1.ed08-97
- Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, et al. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol 1999;49:1493-511 https://doi.org/10.1099/00207713-49-4-1493
- Buriankova K, Doucet-Populaire F, Dorson O, Gondran A, Ghnassia JC, Weiser J, et al. Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex. Antimicrob Agents Chemother 2004;48:143-50 https://doi.org/10.1128/AAC.48.1.143-150.2004
- Nash KA. Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm (38). Antimicrob Agents Chemother 2003;47:3053-60 https://doi.org/10.1128/AAC.47.10.3053-3060.2003
- Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 2005;55:170-7 https://doi.org/10.1093/jac/dkh523
- Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother 2006;50:3476-8 https://doi.org/10.1128/AAC.00402-06
- Meier A, Kirschner P, Springer B, Steingrube VA, Brown BA, Wallace RJ Jr, et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 1994;38:381-4 https://doi.org/10.1128/AAC.38.2.381
- Nash KA, Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995;39:2625-30 https://doi.org/10.1128/AAC.39.12.2625
- Wallace RJ Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-81
- Coleman K, Athalye M, Clancey A, Davison M, Payne DJ, Perry CR, et al. Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother 1994;33: 1091-116 https://doi.org/10.1093/jac/33.6.1091
- Fierro JF, Hardisson C, Salas JA. Involvement of cell impermeability in resistance to macrolides in some producer streptomycetes. J Antibiot (Tokyo) 1988;41:142-4 https://doi.org/10.7164/antibiotics.41.142
- Honore N, Roche PW, Grosset JH, Cole ST. A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae. Lepr Rev 2001;72:441-8
- NCCLS. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes: approves standard. Wayne, Pennsylvania: NCCLS; 2003
- Douthwaite S, Aagaard C. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23S rRNA peptidyl transferase loop. J Mol Biol 1993;232:725-31 https://doi.org/10.1006/jmbi.1993.1426
- Goldman RC, Kadam SK. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth. Antimicrob Agents Chemother 1989; 33:1058-66 https://doi.org/10.1128/AAC.33.7.1058
- Andersson S, Kurland CG. Elongating ribosomes in vivo are refractory to erythromycin. Biochimie 1987;69: 901-4 https://doi.org/10.1016/0300-9084(87)90218-5
- Menninger JR. Mechanism of inhibition of protein synthesis by macrolide and lincosamide antibiotics. J Basic Clin Physiol Pharmacol 1995;6:229-50
- Champney WS, Tober CL. Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Curr Microbiol 1999;38:342-8 https://doi.org/10.1007/PL00006814